Week 2 Flashcards

1
Q

List the Pros and Cons of Topical administration?

A

Pros

- Easy 
- Convenient 
- Self-administered
- Targeted therapy to the eye
- Less systemic side effects

Cons
- Eyes designed to keep things out
- High local concentrations required
Drug drains into the systemic circulation (occlude the puncta to counter this)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the types of topical ocular medications (formulations)?

A

Eye Drops

  • Solutions
  • Suspensions

Gels and Ointments

  • cream
  • gel
  • lotion
  • ointment
  • paste

Ocular Inserts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the effective dose?

A

dose at which response is 50% of maximum effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What the is drug bioavailabilty?

A

Amount of drug available at desired receptor site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are active ingredients in ophthalmic drug formulations?

A
  • It is the therapeutic or diagnostic drug
    • Can affect uptake/absorption through changes in tissue permeability, blood flow and fluid secretion (examples below)
    • Affecting corneal epithelium, e.g. pilocarpine and cocaine
    • Decrease aqueous humour formation, which slows removal of the drug, e.g. dorzolamide
      Can come in drug salts, nanoparticles, mixed with other molecules
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What Drug schedule are local anaesthetics?

A

Schedule 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the 3 schedules that optometrist can use drugs from?

A

Schedule 2, 3 and 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are preservatives in ophthalmic drug formulations?

A

Surfacts, chemical toxins and antiodative and others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List the 4 types of Preservatives?

A

○ Surfactants
○ Chemical toxins
○ Oxidative preservatives
Miscellaneous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Give an example of 3 common preservatives?

A
  • Benzalkonium chloride (BAK)
    • Chlorhexidine
    • Mercurials
    • Chlorobutanol
    • Ethylenediaminetetraacetic acid (ETDA)
    • Stabilized oxychloro-complex (purite), sodium perborate
      SofZia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are surfactants in ophthalmic drug formulations?

A
  • Surfactants (most common)

- Ionically charged molecules that disrupt plasma membrane; usually bactericidal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Common facts about Benzalkonium Chloride (BAK)

A

○ Found in household cleaning products
○ Single drop of 0.01% BAK can break the tear film lipid layer, e.g. like putting detergent on oil
○ Toxic to the corneal epithelium; increased drug penetration
§ Toxicity increases with acidity of the solution
§ Particularly high risk of toxicity with increased used, e.g. anti-inflammatory drops
§ Very low concentrations (e.g. 0.00001% BAK) arrests cell growth and death in the corneal conjunctiva
Stable, excellent antimicrobial properties, long shelf life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Common facts about Chlorhexidine

A

○ Works similarly to BAK; often used at lower concentration than BAK so does not alter corneal permeability
○ Due to structure, does not disturb the lipid layer the same way as BAK, also toxicity neutralised by tear film
Also an active ingredient used for treating Acanthamoeba keratitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Common facts about Polyquaternium - 1 (polyquad)

A

○ Detergent-like quaternary ammonium

Larger molecule than BAK so is not internalized by the corneal epithelium (in mammalian cells) – less toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Common facts about Thimerosal (Chemical toxins)

A

§ Mercury-based chemical, highly effective against fungi
§ Most effective in weakly acidic nitrate
§ Patients can develop sensitivity, e.g. allergic reaction in the conjunctiva
Needs to present in high continuous concentrations to have a biologic effect; diluted by tear film to prevent corneal epithelial toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Common facts aboout Chlorobutanol (chemical toxin)

A

○ Alcohol based chemical, less effective compared to BAK, loss from bottles in prolonged storage
○ Can affect many microbes but not highly effective when used alone
○ Often used with ethylenediaminetetraacetic acid (ETDA)
§ ETDA is a chelating agent: reacts with metal ions to form a stable water-soluble complex
By itself, ETDA is not highly toxic but can cause contact dermatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are some common - oxidatives?

A

Stabilized Oxychloro Complex (Purite, OcuPure)

Sodium Perborate

Oxidative preservatives can be neutralized by mammalian cells; no accumulation, and less toxic than chemical toxins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Common facts about Oxycholoro Complex

A

○ Stabilized Oxychloro Complex (Purite, OcuPure)
§ Oxidases microbial cellular components but does not significantly affect human ocular tissues
§ Breaks down into water and sodium chloride when exposed to light
Purite is found in alphagan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Common facts aobut Sodium Perborate

A

○ Sodium perborate
§ Alters protein synthesis within bacterial cell
Converted into hydrogen peroxide and then broken down into oxygen and water in the eye by catalase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Common facts about other preservatives

A

○ Sofzia (boric acid, propylene glycol, sorbitol, zinc chloride)
§ Ionic buffer, works similar to a detergent or surfactant (causes oxidative damage and death of cells that do not have cytochrome oxidase or catalase enzymes), converted to non-toxic components on contact with cations on the ocular surface
§ Found in travoprost
§ Causes less superficial epithelial punctate staining of the cornea compared to BAK
Protects against a wide range of microbes e.g. pseudomonas aeruginosa, candida albicans, aspergillus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the benefits of viscosity agents?

A

Help with osmolarity, pH, thickness of the drug, increase time the drug stays on the eye

○ Delay washout from the tear film, increase bioavailability Can affect vision, cause blur

Some viscosity polymers contain both hydrophilic and lipophilic sites, enables better combination with different drugs

	○ Nonlinear relationship between molecular weight and concentration; viscosity needs to be measured at the appropriate concentration of the drug Can interact with drug salts to change viscosity; maybe incompatible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the types of viscosity agents and how do they differ?

A

○ Polyionic molecules
§ Bind to corneal surface, increase drug retention, stabilize the tear film (eye drops and gels
○ Petrolatum or oil-based
Provide longer retention of drugs on the eye, acts a temporary lipid depot (ointments); generally thicker than polyionic molecules

	○ Gel-forming systems (e.g. Gelrite) 
		§ Large molecules that change with temperature, pH and electrolyte composition
		§ Forms a clear gel by binding to cations found in the tears to prolong corneal penetration and drug action Increased viscosity = blurred vision
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are some common viscosity agents?

A
  • Polyvinylpyrrolidone
    • Polyvinyl alcohol
    • Hydroxypropyl methylcellulose
    • Carboxymethylcellulose
      Sodium hyaluronate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What do wetting agents do?

A
  • Wetting agents
    ○ Increase spreading and penetrating properties of a drug by lowering surface tension; increases contact time
    • Buffer (changes pH of a solution)
      ○ Drug stability is very important; storage in different conditions and varying amounts of time
      § If a drug less than 18 months shelf life, would be impractical as unable to distribute to other locations
      ○ Drugs (particularly weak bases) that are formulated in an acidic solution are more stable than at a neutral or alkaline pH
      ○ Low concentration buffer allows tears to re-establish normal pH after drug instillation
      Some drugs break down quickly as soon as it dissolves, can use a physical barrier
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What does osmolarity do?

A
  • Osmolarity
    ○ Usually, combination of active drug, preservative and vehicle results in a hypotonic solution
    ○ Simple or complex salts, buffering agents or certain sugars can be added to adjust osmolarity to 290 mOsm/L (isotonic solution = 0.9% saline)
    § Creates drug osmotic gradient to allow drug into the eye
    Increasing tonicity above tears causes dilution of the tears, and there
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Common facts about eye drops - ocular solutions

A
○ Most common
		○ Drug salt dissolved
		○ High concentrations
		○ Risk of stinging
		○ Low cost
		○ High patient acceptance
Low absorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Common facts about eye drops - ocular suspensions

A

○ Salt suspended in liquid
○ Sterilizations required
○ Requires shaking (20 times - 1 minute)
○ Low bioavailability due to manufacturing
○ High concentrations
Higher cost to make

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

How do you instill eye drops?

A
  1. Hand hygiene
    1. Check drops
      a. Shake suspensions
    2. Head, eye, finger co - ordination; drop
    3. Blinking vs closing eye
    4. Wait before next drop (5 - 10 minutes)
29
Q

Common facts about ocular gels?

A
  • Water soluble
    • Increased viscosity
    • Blurred vision
    • Usually administered at night
    • Matted eyelids
      In-situ-activate gel - form systems
30
Q

Common facts about ocular ointments

A
  • Resistant to nasolacrimal drainage
    • Increased eye surface contact area
    • Resistant to dilution by tears
    • Interferes with vision
    • Associated with discomfort and irritation
      Less patient acceptability
31
Q

How to instill eye ointments?

A
  1. Hand hygiene
    1. Check eye ointment
    2. Head, eye, finger co - ordination; 1 cm in pouch
    3. Blink
    4. Use ointment last
      Thick ointment = blurry vision
32
Q

What are the 3 types of colloidal systems?

A
  • Liposomes – Eye spray (lubricating eye spray)
    • Emulsions – Eye drop (Restasis – cyclosporine, Durezol - corticosteroid)
      Nanoparticles – Eye drop (Ganciclovir ophthalmic gel – antiviral)
33
Q

Common facts about Liposomes - colloidal delivery systems

A
  • Microscopic vesicles of lipid bilayers surrounding aqueous compartments
    • Lipid layers can be broken down and are biocompatible
    • Demonstrate a prolonged drug effect at the site of action but with reduced toxicity
    • Used in topical, subconjunctival, intravitreal formulations
    • Surface can have altered properties to help with absorption
    • Challenges:
      ○ Generally more expensive to make compared to solutions, and few commercially available products for topical administration
      ○ There can be leakage and fusion of the encapsulated drug or molecules
34
Q

Common facts about emulsions - colloidal delivery systems

A
  • Two or more liquids that do not dissolve into each other
    • Requires a surfactant to help the liquids mix
    • Results in a mixture of oily phase, aqueous phase, surfactant
    • Has low interfacial tension
      ○ Good at wetting a surface and for spreading
      ○ Sustained release
      ○ Capable of dissolving drugs with different properties
    • Are thermodynamically unstable – need to prevent emulsion from separating into the two phases
      ○ Difficult to manufacture
      ○ Storage conditions may affect stability
      Uniform and accurate dose may not be achieved
35
Q

Common facts about nanoparticles and nanosystems - colloidal delivery systems

A
  • Polymeric colloidal particles that contain drug-entrapped molecules, e.g. small proteins and natural/ synthetic polymers with different types of lipids
    ○ Drug particles are <100nm in size
    ○ Nanotechnology systems are less than 1000nm in size
    ○ small size reduces eye irritability and reduced degradation
    • Help to extend and control the release of therapeutic agents by enhancing drug solubility, bioavailability and stability, through targeted delivery, sustained release or increasing shelf-life
      ○ Maybe in the future used for reaching the posterior eye
    • Physical and functional properties can be easily altered
    • Surface properties of the particles can be modified and affect the intraocular distribution of the drug
      ○ Can improve absorption but can also interact with biological systems
      ○ Particles may grow in size and aggregate inside the tissues
      Challenges: few polymeric materials available, difficulty of producing selective targeting, high cost to develop and be approved for use
36
Q

What are the two types of topical inserts?

A

Ocusert

Lacrisert

37
Q

Common facts about Ocusert

A
  • E.g. Pilocarpine
    - Advantages: effective, continuous release, better for those unable to self-administer
    Disadvantages: need instruction and encouragement, retention difficulties, hard to tell when device lost, side effects
38
Q

Common facts about Lacrisert

A
  • For dry eye
    - Advantage: removes need for multiple drops/day, maybe better for those unable to self - administer
    Side effects
39
Q

What are some other topical administration?

A
  • Contact lenses (increase in bioavailability, but high cost and complicated processing)
    • Collagen shields (deliver drugs and promote corneal epithelial healing; pre-soaked collagen shields may deliver drugs better than traditional methods)
      Iontophoresis (uses an electrical current to carry ionized drug across tissue; trans corneal iontophoresis delivers high concentrations of drug to the anterior segment of the eye)
40
Q

What factors effect Ocular absorption?

A
• Drug properties
	- pH
	- Viscosity
	- Preservatives
	- ‘Stinging/irritation’
• Punctal occlusion
• Delivery aids
• Patient ‘properties’
	- Inflammation
	- Elderly
	- child crying
Damaged epithelium
41
Q

What are the 3 techniques to help optimize drug administration?

A
  • Increase corneal permeablity
  • increase corneal contact time
  • slow release of drug into the eye (to reduce pulse entry)
42
Q

What are way to increase corneal permeability?

A
Prodrugs
Penetration enhancers
	Surfactants
	Bile salts
	Fatty acids
	Ion pairs
        Cyclodextrans
43
Q

What are ways to increase corneal contact time?

A

Viscosity enhancement
Polymers (e.g. HPMC, PVA, carbomers)
In situ gelling systems
- Solution to gel phase

44
Q

What are ways for slow release of drug into the eye (to reduce pulse entry)

A

Colloidal delivery systems
- Microemulsions
- Liposomes
Polymer particulate systems (microsphere and nanoparticles)

45
Q

General info about eye drops

A
  • Too many drops = washout, ↑systemic absorption
    • 5 minutes between drops = ~ 0% washout
    • ~20 drops per mL of eye drop (how many in 5 mLs?)
    • Use up to 28 days after opening
    • ‘Minims’ are a single use drop device
    • No preservatives
  • Final result of eye drop instillation = ~1-7% reaches target tissue
46
Q

Common facts about oral drug delivery

A
  • Access to sites that topical medications cannot access
    - Analgesia
    • Can exert greater effect on lowering acute IOP changes
    • Prophylaxis and adjunct
    • Increased systemic side effects
      Blood barriers impairs drug delivery to eye
47
Q

Common facts about Non ocular injections

A
  • Intravenous
    • Antibiotics/anti-inflammatories
    • Dyes for ocular imaging
  • Testing for certain disease
48
Q

Common facts about Intra-muscular injectiosn

A
  • Limited use in eye care
  • Mainly used to treat systemic infections with ocular manifestations, e.g. gonococcal infection (antibiotics), or contact dermatitis, or botox for blepharospasm, extraocular, muscle disturbances; anaesthetics for extraocular muscles
49
Q

What are the types of ocular injections?

A
  • Subconjunctival
  • Subtenon’s
  • Subcutaneous
  • Intra - lesional
  • Intra - cameral
  • Retro - bulbar
  • Intravitreal
50
Q

What are the 5 types of ocular implants?

A
Intravitreal devices
	a. Vitrasert
	b. Retisert
	c. Medidur
	d. I-vation
Ozurdex
51
Q

What are subconjunctival injections?

A
  • Depot steroid injections
    - Often long - acting steroid (e.g. refractory uveitis, cystoid macular oedema) or antibiotic (e.g. severe corneal ulcers, endophthalmitis)
    Can induce IOP elevation
52
Q

What are subtenons injection

A
  • Similar to sub-conjunctival (no apparent advantage), but penetrates Tenon’s capsule
    For pars planitis, intermediate uveitis, cystoid macular oedema
53
Q

What are subcutenous injections?

A

For periocular anaesthetics, adrenaline for anaphylaxis (EpiPen)

54
Q

What are intra-lesional injections?

A

Deliver drugs to chalazia or pyogenic granulomas (steroids)

55
Q

What are intra - cameral injections

A
  • Deliver drugs within a chamber, usually anterior chamber
    For antiobiotics for corneal ulcer, viscoelastic administration to protect the corneal endothelium during cataract surgery
56
Q

What are retro - bulbar injections?

A
  • Anaesthetic administration for eye surgery
    - Retrobulbar block involves depositing local anaesthetic inside the muscle cone
    Aims to block ciliary nerves, ciliary ganglion, cranial nerves (III, IV, VI)
57
Q

What are intra - vitreal injections?

A
  • Most common intraocular injection
    Mainly for conditions affecting posterior eye, e.g. anti -vascular endothelial growth factor for neovascularization, steroid injections for tumours or diabetes
58
Q

Define schedule 2 Drugs

A

Pharmacy medicine - substances, the safe use of which may require advice from a pharmacist and which should be available from a pharmacy or, where a pharmacy service is not available, from a licensed person.

59
Q

Define Schedule 3 Drugs

A

Pharmacist Only medicine - Substances, the safe use of which requires professional advice but which should be available to the public from a pharmacist without a prescription.

60
Q

Define Schedule 4 Drugs

A

Prescription Only medicine, or Prescription Animal Remedy - Substances, the use or supply or which should be by or on the order of persons permitted by State or Territory legislation to prescribe and should be available from a pharmacist on prescription.

61
Q

Define Category A Drug (pregnancy)

A

Drugs which have been taken by a large number of pregnant women and women of childbearing age without any proven increase in the frequency of malformations or other direct or indirect harmful effects on the fetus having been observed.

62
Q

Define Category B1 Drug (pregnancy)

A

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed.

Studies in animals have not shown evidence of an increased occurrence of fetal damage.

63
Q

Define Category B2 Drug (pregnancy)

A

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed.

Studies in animals are inadequate or may be lacking, but available data show no evidence of an increased
occurrence of fetal damage.

64
Q

Define Category B3 Drug (pregnancy)

A

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed.

Studies in animals have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans

65
Q

Define Category C Drug (pregnancy)

A

Drugs which, owing to their pharmacological effects, have caused or may be suspected of causing, harmful
effects on the human fetus or neonate without causing malformations. These effects may be reversible.
Accompanying texts should be consulted for further details

66
Q

Define Category D Drug (pregnancy)

A

Drugs which have caused, are suspected to have caused or may be expected to cause, an increased incidence of human fetal malformations or irreversible damage. These drugs may also have adverse pharmacological effects. Accompanying texts should be consulted for further details.

67
Q

Define Category X Drug (pregnancy)

A

Drugs which have such a high risk of causing permanent damage to the fetus that they should not be used in pregnancy or when there is a possibility of pregnancy.

68
Q

Consideration when prescribing for pregnant people

A
  • Human data are lacking or inadequate for drugs in the B1, B2 and B3 categories
    • Sub-categorisation of the B category is based on animal data
    • The allocation of a B category does not imply greater safety than a C category
    • The allocation of a B category does not imply greater than a C category
    • Medicines in category D are not absolutely contraindicated during pregnancy
      Consider risk vs benefit